← SynDRA
GUANADREL
SynDRA canonical compound SYN0003302 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | SLC6A2 |
|---|
| Mechanism of action | Adrenergic inhibitor |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- Adrenergic inhibitor
- SLC6A2 SUBSTRATE
- Norepinephrine transporter substrate
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Antihypertensive Agents
- Cardiovascular Agents
Cross-references
Synonyms
- HYLOREL
- hylorel
- guanadrel sulfate
- Guanadrel Sulfate
- Hylorel
- Hyloride
- Guanadrel sulfate [USAN]
- CL-1388R
- U-28288D
- Guanadrel sulfate (USP)
- Hylorel (TN)
- U 28,288D
- Guanadrel sulfate (2:1)
- Guanadrelum
- CHEBI:5555
- 1-{1,4-dioxaspiro[4.5]decan-2-ylmethyl}guanidine
- RefChem:144631
- DTXCID8028000
- Guanadrel [INN]
- Guanadrelum [INN-Latin]
- Guanadrel (INN)
- UNII-765C9332T4
- GUANADREL [MI]
- Prestwick0_000767
- Prestwick1_000767
- Prestwick2_000767
- Prestwick3_000767
- GUANADREL [VANDF]
- GUANADREL [WHO-DD]
- BSPBio_000814
- SCHEMBL180963
- SPBio_002753
- BPBio1_000896
- GTPL7193
- orb1685321
- SCHEMBL23858317
- EX-A4513
- EBC-44031
Look up GUANADREL in the interactive SynDRA portal →